Tirzepatide 20mg
CAS Number: 2023788192 Disclaimer: For research use only. Not for human consumption. Intended for laboratorybased studies by qualified professionals. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. Overview: Tirzepatide is a dual incretin mimetic peptide studied for its potent effects on metabolic regulation, appetite suppression, and insulin sensitivity. It acts as a dual agonist at both the GLP1 and GIP receptors, offering a nextgeneration approach to weight management and glycemic control in metabolic research models. Mechanism of Action: GLP1 receptor activation promotes insulin secretion, reduces glucagon output, delays gastric emptying, and increases satiety through central nervous system signaling. GIP receptor activation enhances glucosedependent insulin release and supports lipid metabolism and energy utilization. Specifications: Form: Lyophilized powder (researchgrade) Purity: ≥99% (HPLCtested) Storage: Store refrigerated (2–8°C), protected from light and humidity. For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Purity specification: ≥99% (HPLC-tested). CAS number: 2023788-19-2. Category: GLP-1.
For research use only. Not for human consumption.